An interventional study of virtual reality upper limb hand training and virtual reality control training in Parkinson Disease, sponsored by Luzerner Kantonsspital. Recruiting at 1 site in Switzerland. Open to participants aged 40 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-07-28.
Sponsored by Luzerner Kantonsspital · Not applicable, Interventional, and Treatment
We investigate the impact of a 4-week virtual reality-based upper limb training in Parkinson's disease. The benefits on dexterity of this training program will be evaluated.
For these purposes, a randomised, two arm, single assessor blind, parallel design with a monocentric, study setup will be performed.
Patients with Parkinson's disease (PD) suffer from significantly decreased coordination and have difficulties with precise hand/finger movements during the performance of both basic activities of daily living (ADL), such as dressing, grooming as well as higher ADL, such as cooking, shopping and regular medication intake. These difficulties further add to the burden of the disease, leading to reduced quality of life (QoL). A relatively new, but rapidly growing aspect of training in PD neurorehabilitation offers virtual reality (VR). We explore the effects of a VR-based upper limb hand training compared to a VR control training, which is less specific for dexterity. Moreover, we examine the effetcs of the trainings on upper limb related ADL, and therefore the impact on QoL in patients with PD.
4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.
This study's planned enrollment of 20 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.
Browse Parkinson Disease studies →Luzerner Kantonsspital is the lead sponsor of 60 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The PD patients randomized in the experimental group will receive virtual reality upper limb hand training.
Other: virtual reality upper limb hand training
The PD patients randomized in the control group will receive virtual reality control training.
Other: virtual reality control training
The PD patients randomized in the experimental group will receive virtual reality upper limb hand training.
The PD patients randomized in the control group will receive virtual reality control training.
fine finger movements
Coin rotation task (CRT): The CRT measures fine coordinated finger movements and is a suitable and valid dexterity test in patients with PD. The seconds for 20 halfturns will be measured.
Time frame: 4 weeks
hand dexterity
Nine Hole Peg test (9-HPT): The 9-HPT is a standardized, well established, and reliable measure of hand dexterity in patients with PD. seconds will be measured.
Time frame: 4 weeks
grip strenght
The handheld JAMAR dynamometer measures the grip strength. kg will be measured.
Time frame: 4 weeks
motor function
MDS-Sponsored Revision of the Unified Parkinson Disease Rating Scale (MDS-UPDRS III): It evaluates motor aspects of Parkinson's disease
Time frame: 4 weeks
self-reported dexterity related problems in daily living
Dexterity Questionnaire 24 (DextQ-24): This questionnaire is a standardized patient self-rated outcome measure (PROM) for evaluating dexterity related ADL in PD. score range 24-96, higher scores mean more dexterity problems.
Time frame: 4 weeks
self-reported problems in quality of life
Parkinson's Disease Questionnaire (PDQ-39): This questionnaire is a standardized patient self-rated outcome measure (PROM) for evaluating QOL in PD. range 0-156, higher values mean more problems.
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Luzerner Kantonsspital